Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological actions of oncogenes

M R Smith1, N T Matthews, K A Jones

  • 1Biological Carcinogenesis and Development Program, Program Resources Inc., DynCorp, National Cancer Institute, Frederick Cancer Research and Development Center, MD 21702.

Pharmacology & Therapeutics
|January 1, 1993
PubMed
Summary

Cancer arises from multistep genetic mutations, often involving proto-oncogenes and tumor suppressor genes. Understanding their normal functions versus their roles in oncogenic transformation is key to cancer research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential gene expression profile of CD4+/CD8+ T cells in patients with hepatitis C virus and/or human immunodeficiency virus infection.

Hong Kong medical journal = Xianggang yi xue za zhi·2016
Same author

Decreased expression of H3K27me3 in human ovarian carcinomas correlates with more aggressive tumor behavior and poor patient survival.

Neoplasma·2015
Same author

MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.

Oncogene·2014
Same author

HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.

Cancer gene therapy·2012
Same author

Localization of 5-HT1A and 5-HT2A positive cells in the brainstems of control age-matched and Alzheimer individuals.

Age (Dordrecht, Netherlands)·2010

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Cancer develops through accumulated genetic mutations.
  • Specific genes are susceptible to mutations due to chromosomal location or cell cycle control roles.
  • Dysregulation of growth/differentiation pathways or cell cycle inhibitors activates oncogenesis.

Purpose of the Study:

  • To compare the normal functions of proto-oncogenes with the transforming activities of oncogenes.
  • To explore the roles of tumor suppressor genes in cancer development.
  • To discuss potential mechanisms driving oncogenic transformation.

Main Methods:

  • Review of existing literature on oncogenes and tumor suppressor genes.
  • Comparative analysis of gene functions in normal versus cancerous cells.

Related Experiment Videos

  • Discussion of molecular mechanisms underlying oncogenic transformation.

    • Main Results:

    • Proto-oncogenes regulate normal cell growth and differentiation.
    • Oncogenes result from mutated proto-oncogenes, promoting uncontrolled cell proliferation.
    • Tumor suppressor genes normally inhibit cell growth; their inactivation contributes to cancer.

    Conclusions:

    • Understanding oncogenes and tumor suppressor genes is crucial for deciphering cancer's molecular origins.
    • Mechanisms of oncogenic transformation involve the interplay between these gene types.
    • Further research into these genetic factors can inform cancer prevention and treatment.